430 related articles for article (PubMed ID: 18843795)
21. Combined Blockade of MEK and CDK4/6 Pathways Induces Senescence to Improve Survival in Pancreatic Ductal Adenocarcinoma.
Willobee BA; Gaidarski AA; Dosch AR; Castellanos JA; Dai X; Mehra S; Messaggio F; Srinivasan S; VanSaun MN; Nagathihalli NS; Merchant NB
Mol Cancer Ther; 2021 Jul; 20(7):1246-1256. PubMed ID: 34001634
[TBL] [Abstract][Full Text] [Related]
22. Tumor suppressor p16INK4A is necessary for survival of cervical carcinoma cell lines.
McLaughlin-Drubin ME; Park D; Munger K
Proc Natl Acad Sci U S A; 2013 Oct; 110(40):16175-80. PubMed ID: 24046371
[TBL] [Abstract][Full Text] [Related]
23. p16(Ink4a)-induced senescence of pancreatic beta cells enhances insulin secretion.
Helman A; Klochendler A; Azazmeh N; Gabai Y; Horwitz E; Anzi S; Swisa A; Condiotti R; Granit RZ; Nevo Y; Fixler Y; Shreibman D; Zamir A; Tornovsky-Babeay S; Dai C; Glaser B; Powers AC; Shapiro AM; Magnuson MA; Dor Y; Ben-Porath I
Nat Med; 2016 Apr; 22(4):412-20. PubMed ID: 26950362
[TBL] [Abstract][Full Text] [Related]
24. S-phase lengthening induced by p16(INK4a) overexpression in malignant cells with wild-type pRb and p53.
Chien WW; Domenech C; Catallo R; Salles G; Ffrench M
Cell Cycle; 2010 Aug; 9(16):3286-96. PubMed ID: 20703084
[TBL] [Abstract][Full Text] [Related]
25. Familial melanoma-associated mutations in p16 uncouple its tumor-suppressor functions.
Jenkins NC; Jung J; Liu T; Wilde M; Holmen SL; Grossman D
J Invest Dermatol; 2013 Apr; 133(4):1043-51. PubMed ID: 23190892
[TBL] [Abstract][Full Text] [Related]
26. Compromising the constitutive p16
Kanugovi AV; Joseph C; Siripini S; Paithankar K; Amere SS
J Cell Biochem; 2020 Apr; 121(4):2770-2781. PubMed ID: 31692039
[TBL] [Abstract][Full Text] [Related]
27. CDK4/6 and IGF1 receptor inhibitors synergize to suppress the growth of p16INK4A-deficient pancreatic cancers.
Heilmann AM; Perera RM; Ecker V; Nicolay BN; Bardeesy N; Benes CH; Dyson NJ
Cancer Res; 2014 Jul; 74(14):3947-58. PubMed ID: 24986516
[TBL] [Abstract][Full Text] [Related]
28. Significant role for p16INK4a in p53-independent telomere-directed senescence.
Jacobs JJ; de Lange T
Curr Biol; 2004 Dec; 14(24):2302-8. PubMed ID: 15620660
[TBL] [Abstract][Full Text] [Related]
29. p16(INK4a) and the control of cellular proliferative life span.
Huschtscha LI; Reddel RR
Carcinogenesis; 1999 Jun; 20(6):921-6. PubMed ID: 10357768
[TBL] [Abstract][Full Text] [Related]
30. Senescence delay of human diploid fibroblast induced by anti-sense p16INK4a expression.
Duan J; Zhang Z; Tong T
J Biol Chem; 2001 Dec; 276(51):48325-31. PubMed ID: 11606567
[TBL] [Abstract][Full Text] [Related]
31. A senescence program controlled by p53 and p16INK4a contributes to the outcome of cancer therapy.
Schmitt CA; Fridman JS; Yang M; Lee S; Baranov E; Hoffman RM; Lowe SW
Cell; 2002 May; 109(3):335-46. PubMed ID: 12015983
[TBL] [Abstract][Full Text] [Related]
32. G1 arrest by p16INK4A uncouples growth from cell cycle progression in leukemia cells with deregulated cyclin E and c-Myc expression.
Ausserlechner MJ; Obexer P; Geley S; Kofler R
Leukemia; 2005 Jun; 19(6):1051-7. PubMed ID: 15800668
[TBL] [Abstract][Full Text] [Related]
33. Guilu Erxian Glue () Inhibits Chemotherapy-Induced Bone Marrow Hematopoietic Stem Cell Senescence in Mice May via p16
Wang J; Ying YY; Chen ZH; Shao KD; Zhang WP; Lin SY
Chin J Integr Med; 2020 Nov; 26(11):819-824. PubMed ID: 32915425
[TBL] [Abstract][Full Text] [Related]
34. Tumor suppressor and aging biomarker p16(INK4a) induces cellular senescence without the associated inflammatory secretory phenotype.
Coppé JP; Rodier F; Patil CK; Freund A; Desprez PY; Campisi J
J Biol Chem; 2011 Oct; 286(42):36396-403. PubMed ID: 21880712
[TBL] [Abstract][Full Text] [Related]
35. Expression of p16Ink4a compensates for p18Ink4c loss in cyclin-dependent kinase 4/6-dependent tumors and tissues.
Ramsey MR; Krishnamurthy J; Pei XH; Torrice C; Lin W; Carrasco DR; Ligon KL; Xiong Y; Sharpless NE
Cancer Res; 2007 May; 67(10):4732-41. PubMed ID: 17510401
[TBL] [Abstract][Full Text] [Related]
36. Biallelic mutations in p16(INK4a) confer resistance to Ras- and Ets-induced senescence in human diploid fibroblasts.
Huot TJ; Rowe J; Harland M; Drayton S; Brookes S; Gooptu C; Purkis P; Fried M; Bataille V; Hara E; Newton-Bishop J; Peters G
Mol Cell Biol; 2002 Dec; 22(23):8135-43. PubMed ID: 12417717
[TBL] [Abstract][Full Text] [Related]
37. Wnt9a Promotes Renal Fibrosis by Accelerating Cellular Senescence in Tubular Epithelial Cells.
Luo C; Zhou S; Zhou Z; Liu Y; Yang L; Liu J; Zhang Y; Li H; Liu Y; Hou FF; Zhou L
J Am Soc Nephrol; 2018 Apr; 29(4):1238-1256. PubMed ID: 29440280
[TBL] [Abstract][Full Text] [Related]
38. Mutational analysis of selected genes in the TGFbeta, Wnt, pRb, and p53 pathways in primary uveal melanoma.
Edmunds SC; Kelsell DP; Hungerford JL; Cree IA
Invest Ophthalmol Vis Sci; 2002 Sep; 43(9):2845-51. PubMed ID: 12202501
[TBL] [Abstract][Full Text] [Related]
39. Regulation of Tumor Suppressor Gene CDKN2A and Encoded p16-INK4a Protein by Covalent Modifications.
Jiao Y; Feng Y; Wang X
Biochemistry (Mosc); 2018 Nov; 83(11):1289-1298. PubMed ID: 30482142
[TBL] [Abstract][Full Text] [Related]
40. Protection against chemotherapy-induced cytotoxicity by cyclin-dependent kinase inhibitors (CKI) in CKI-responsive cells compared with CKI-unresponsive cells.
Schmidt M; Fan Z
Oncogene; 2001 Sep; 20(43):6164-71. PubMed ID: 11593424
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
